The neuropsychology of normal aging and preclinical Alzheimer's disease

Alzheimer's and Dementia

Volumn 10, Issue 1, 2014, Pages 84-92

  Caselli, Richard J ^a   Locke, Dona E C ^a   Dueck, Amylou C ^a   Knopman, David S ^b   Woodruff, Bryan K ^a   Hoffman Snyder, Charlene ^a   Rademakers, Rosa ^c   Fleisher, Adam S ^d   Reiman, Eric M ^d  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

^c MAYO CLINIC   (United States)

^d BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

Age related memory loss; Apolipoprotein E; Cognitive aging; Longitudinal testing; Mild cognitive impairment; Preclinical Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; CROSS-SECTIONAL STUDY; DEMENTIA RATING SCALE; EXECUTIVE FUNCTION; FEMALE; GENE DOSAGE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RATING SCALE; VERY ELDERLY; WISCONSIN CARD SORTING TEST; YOUNG ADULT;

AGE-RELATED MEMORY LOSS; APOLIPOPROTEIN E; COGNITIVE AGING; LONGITUDINAL TESTING; MILD COGNITIVE IMPAIRMENT; PRECLINICAL ALZHEIMER'S DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; LANGUAGE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84891162486     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2013.01.004     Document Type: Article

References (50)

1. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
2. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, and S.H. Joo et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472 (Pubitemid 23230526)
3. R.J. Caselli, A.C. Dueck, D. Osborne, M.N. Sabbagh, D.J. Connor, and G.L. Ahern et al. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect N Engl J Med 361 2009 255 263
4. D.B. Howieson, N.E. Carlson, M.M. Moore, D. Wasserman, C.D. Abendroth, and J. Payne-Murphy et al. Trajectory of mild cognitive impairment onset J Int Neuropsychol Soc 14 2008 192 198 (Pubitemid 351279998)
5. C. Bouras, P.R. Hof, P. Giannakopoulos, J.P. Michel, and J.H. Morrison Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital Cereb Cortex 4 1994 138 150 (Pubitemid 24127824)
6. H. Braak, and E. Braak Frequency of stages of Alzheimer-related lesions in different age categories Neurobiol Aging 18 1997 351 357 (Pubitemid 27435070)
7. E.M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu, and W. Lee et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Proc Natl Acad Sci U S A 106 2009 6820 6825
8. E.C. Mormino, J.T. Kluth, C.M. Madison, V.D. Rabinovici, S.L. Baker, and B.L. Miller et al. Episodic memory loss is related to hippocampal-mediated B-amyloid deposition in elderly subjects Brain 132 2008 1310 1323
9. W.E. Klunk, J.C. Price, C.A. Mathis, N.D. Tsopelas, B.J. Lopresti, and S.K. Ziolko et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees J Neurosci 27 2007 6174 6184 (Pubitemid 46890033)
10. V.L. Villemagne, K.E. Pike, D. Darby, B. Maruff, G. Savage, and S. Ng et al. AB deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease Neuropsychologia 46 2008 1688 1697
11. G.B. Frisoni, M. Lorenzi, A. Caroli, N. Kemppainen, K. Nagren, and J.O. Rinno In vivo mapping of amyloid toxicity in Alzheimer disease Neurology 72 2009 1504 1511
12. S.M. Resnick, J. Sojkova, Y. Zhou, Y. An, W. Ye, and D.P. Holt et al. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB Neurology 74 2010 807 815
13. R.L. West An application of prefrontal cortex function theory to cognitive aging Psychol Bull 120 1996 272 292 (Pubitemid 126690074)
14. P. Verhaeghen, and J. Cerella Aging, executive control, and attention: a review of meta- analyses Neurosci Behav Rev 26 2002 849 857
15. F.H. Treitz, K. Heyder, and I. Daum Differential course of executive control changes during normal aging Aging Neuropsychol Cognition 14 2007 370 393 (Pubitemid 47027108)
16. R.J. Caselli, A.C. Dueck, D.E. Locke, C.R. Hoffman-Snyder, B.K. Woodruff, and S.Z. Rapcsak et al. Longitudinal modeling of frontal cognition in APOE epsilon4 homozygotes, heterozygotes, and noncarriers Neurology 76 2011 1383 1388
17. B.T. Hyman, G.W. Van Hoesen, A.R. Damasio, and C.L. Barnes Alzheimer's disease: cell-specific pathology isolates the hippocampal formation Science 225 1984 1168 1170 (Pubitemid 14029099)
18. R.M. Crum, J.C. Anthony, S.S. Bassett, and M.F. Folstein Population-based norms for the Mini-Mental State Examination by age and education level JAMA 269 1993 2386 2391 (Pubitemid 23129378)
19. M.D. Lezak, D.B. Howieson, and D.W. Loring Neuropsychological assessment 4th ed. 2004 Oxford University Press New York
20. American Psychiatric Association Diagnostic and statistical manual of mental disorders 3rd ed., revised 1987 American Psychiatric Association Washington, DC
21. R.C. Petersen, J.C. Stevens, M. Ganguli, E.G. Tangalos, J.L. Cummings, and S.T. DeKosky Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 2001 1133 1142
22. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 (Pubitemid 14076461)
23. D.E.C. Locke, K.B. Dassel, G. Hall, L.C. Baxter, B.K. Woodruff, and C. Hoffman Synder et al. Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire Dement Geriatr Cogn Disord 27 2009 260 272
24. J.H. Ware, D.W. Dockery, T.A. Louis, X. Xu, B.G. Ferris, and F.E. Speizer Longitudinal and cross-sectional estimates of pulmonary function decline in never-smoking adults Am J Epidemiol 132 1990 685 700 (Pubitemid 20344536)
25. G.M. Fitzmaurice, N.M. Laird, and J.H. Ware Applied longitudinal analysis 2004 Wiley Hoboken, NJ 418-422
26. E. Kok, S. Haikonen, T. Luoto, H. Huhtala, S. Goebeler, and H. Haapasalo et al. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age Ann Neurol 65 2009 650 657
27. J.C. Morris, C.M. Roe, C. Xiong, A.M. Fagan, A.M. Goate, and D.M. Holtzman et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging Ann Neurol 67 2010 122 131
28. D.M. Masur, M. Sliwinski, R.B. Lipton, A.D. Blau, and H.A. Crystal Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons Neurology 44 1994 1427 1432 (Pubitemid 24247431)
29. M.F. Elias, A. Beiser, P.A. Wolf, R. Au, R.F. White, and R.B. D'Agostino The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort Arch Neurol 57 2000 808 813 (Pubitemid 30397182)
30. J. Saxton, O.L. Lopez, G. Ratcliff, C. Dulberg, L.P. Fried, and M.C. Carlson et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to diagnosis Neurology 63 2004 2341 2347 (Pubitemid 40024347)
31. M.C. Tierney, C. Yao, A. Kiss, and I. McDowell Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years Neurology 64 2005 1853 1859 (Pubitemid 40800697)
32. H. Amieva, M. Le Goff, X. Millet, J.M. Orgogozo, K. Peres, and P. Barberger-Gateau et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms Ann Neurol 64 2008 492 498
33. E. Grober, C.B. Hall, R.B. Lipton, A.B. Zonderman, S.M. Resnick, and C. Kawas Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease J Int Neuropsychol Soc 14 2008 266 278 (Pubitemid 351280005)
34. D.K. Johnson, M. Storandt, J.C. Morris, and J.E. Galvin Longitudinal study of the transition from healthy aging to Alzheimer disease Arch Neurol 66 2009 1254 1259
35. R.S. Wilson, S.E. Leurgans, P.A. Boyle, and D.A. Bennett Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment Arch Neurol 68 2011 351 356
36. J.M. Ringman, C. Diaz-Olavarrieta, Y. Rodriguez, M. Chavez, L. Fairbanks, and F. Paz et al. Neuropsychological function in nondemented carriers of presenilin-1 mutations Neurology 65 2005 552 558 (Pubitemid 41170714)
37. M.A. Parra, S. Abrahams, R.H. Logie, L.G. Mendez, F. Lopera, and S. Della Salla Visual short term memory binding deficits in familial Alzheimer's disease Brain 133 2010 2702 2713
38. S.E. MacPherson, M.A. Parra, S. Moreno, F. Lopera, and S. Della Salla Dual task abilities as a possible marker of Alzheimer's disease in carriers of the E280A presenilin-1 mutation J Int Neuropsychol Soc 18 2012 1 8
39. R.J. Bateman, C. Xiong, T.L.S. Benzinger, A.M. Fagan, A. Goate, and N.C. Fox et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
40. B. Reisberg, S.H. Ferris, M.J. De Leon, and T. Crook The Global Deterioration Scale for assessment of primary degenerative dementia Am J Psychiatry 139 1982 1136 1139 (Pubitemid 12051593)
41. H.C. Comijs, D.J.H. Deeg, M.G. Dik, J.W.R. Twisk, and C. Jonker Memory complaints: the association with psych-affective and health problems and the role of personality characteristics: a 6 year follow-up study J Affect Disord 72 2002 157 165 (Pubitemid 35007360)
42. A.F. Jorm, P. Butterworth, K.J. Anstey, H. Christensen, S. Easteal, and J. Maller et al. Memory complaints in a community sample aged 60-64 years: associations with cognitive functioning, psychiatric symptoms, APOE genotype, hippocampus and amygdale volumes, and white matter hyperintensities Psychol Med 34 2004 1495 1506 (Pubitemid 39599947)
43. F. Jessen, B. Wiese, C. Bachman, S. Eifflaender-Gorfer, F. Haller, and H. Kolsch et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment Arch Gen Psychiatry 67 2010 414 422
44. B. Reisberg, M.B. Shulman, C. Torossian, L. Leng, and W. Zhu Outcome over seven years of healthy adults with and without subjective cognitive impairment Alzheimers Dement 6 2010 11 24
45. A. Perrotin, E.C. Mormino, C.M. Madison, A.O. Hayenga, and W.J. Jagust Subjective cognition and amyloid deposition imagine Arch Neurol 69 2012 223 229
46. C.R. Jack Jr., D.S. Knopman, S.D. Weigand, H.J. Wiste, P. Venuri, and V. Lowe et al. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer's disease Ann Neurol 71 2012 765 775
47. D.A. Bennett, P.L. De Jager, S.E. Leurgans, and J.A. Schneider Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles Neurology 72 2009 1495 1503
48. R.J. Caselli, D. Walker, L. Sue, M. Sabbagh, and T. Beach Amyloid load in nondemented brains correlates with APOE e4 Neurosci Lett 473 2010 168 171
49. R.J. Bateman, P.S. Aisen, B. De Strooper, N.C. Fox, C.A. Lemere, and J.M. Ringman et al. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease Alzheimer Res Therapy 3 2011 1
50. E.M. Reiman, J.B. Langbaum, and P.N. Tariot Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible Biomarkers Med 4 2010 3 14